INDUSTRIALISATION
INJECTION
DUAL CHAMBER
FORMULATION
PFS
WEARABLES
ALL INJECTION
OCULAR
ORAL
RESPIRATORY
PULMONARY
NASAL
ALL RESPIRATORY
MORE
INTERVIEWS
EXPERT VIEWS
EARLY INSIGHTS
COMPANY LISTINGS
OUR AUTHORS
THE MAGAZINE
EVENTS
ED CALENDAR
CONTRIBUTE
MEDIA PACK
Subscribe
INDUSTRIALISATION
INJECTION
DUAL CHAMBER
FORMULATION
PFS
WEARABLES
ALL INJECTION
OCULAR
ORAL
RESPIRATORY
PULMONARY
NASAL
ALL RESPIRATORY
MORE
INTERVIEWS
EXPERT VIEWS
EARLY INSIGHTS
COMPANY LISTINGS
OUR AUTHORS
THE MAGAZINE
EVENTS
ED CALENDAR
CONTRIBUTE
MEDIA PACK
SEARCH
SEARCH
advanced search
Connecting Drug Delivery
134
Issue No #134 June 2022
June 8th, 2022
Download PDF
Issue 134 - Jun 2022
Inside the magazine
CONNECTIVITY
Mindy Katz
TURNING CONNECTED DRUG DELIVERY PIPE DREAMS INTO REALITY
Mindy Katz discusses the benefits of integrating homecare technologies that are patient centric and connected.
CONNECTIVITY
Chelsea Williams
SHL Medical
MEETING AN UNMET PHARMA NEED: PIONEERING THE WAY TO A CONNECTED FUTURE
Chelsea Williams, Nagisa Kobashi and Nils Weber discuss the digital transformation of injectables, where drug formulation and device are enmeshed within a connected ecosystem powered by patient data.
CONNECTIVITY
Aurelie Pager
BD (Becton Dickinson & Company)
A PATIENT-CENTRIC, CONNECTED INJECTION DEVICE FOR DECENTRALISED CLINICAL TRIALS – THE HUMAN FACTORS RESULTS ARE IN!
Aurélie Pager and Mircea Despa follow up on an article published in the December 2021 issue of ONdrugDelivery. BD has now completed a human factors study assessing the usability, acceptance and ease of use of its connected injection prototype for clinical trials.
CONNECTIVITY
Dr Andreas Schneider
Ypsomed
PAVING THE WAY TO INTEGRATED DEVICE-DIGITAL SOLUTIONS
Andreas Schneider and Philippe Müller discuss the potential benefits and challenges of implementing connected device-digital solutions within the healthcare sector to improve the treatment of chronic conditions.
EXPERT VIEW
Dr Bernard Vrijens
FOCUS ON ADHERENCE TO EMBRACE DCT BENEFITS
Bernard Vrijens looks at the effect of decentralised clinical trials on medication adherence in clinical studies.
CONNECTIVITY
Gemma Wood
Bespak
CONNECTING PATIENTS AND HEALTHCARE PROVIDERS IN THE AGE OF SELF-ADMINISTERED INJECTABLE DRUGS
Gemma Wood explores connected device development trends, the patient-centric benefits the technology has to offer and how, with the help of experienced manufacturing partners connected to key enabling technology partners, they can develop products that deliver improved patient outcomes.
CONNECTIVITY
Marcel Botha
Aero Pump
A GAME CHANGER FOR HIGH-RISK MEDICATIONS VIA AN INTRANASAL DELIVERY PLATFORM
Marcel Botha, Andreas Bilstein, Houssam Elghobary and Rouven Kraus discuss the benefits of the Validose digital health platform for the safe delivery of high-value and/or high-risk products.
CONNECTIVITY
Dr Mark Allen
Cambridge Design Partnership
THE SMART INHALER REVOLUTION: ARE WE THERE YET?
Mark Allen, David Blakey and Karla Sanchez discuss the benefits of smart inhalers and how they could influence the commercialisation of respiratory drugs in the future.
CONNECTIVITY
Romain Marmot
Aptar Digital Health
HOW DIGITAL THERAPEUTICS ADD VALUE TO TREATMENTS FOR COMPLEX CONDITIONS
Romain Marmot discusses how external partners with a track record of developing digital therapeutics for numerous chronic conditions and therapies can help life science organisations implement digital solutions across their pipeline, adding value to each therapy while improving medication adherence and clinical outcomes.
EXPERT VIEW
Dr Ben Cox
HOW DIGITAL UX IN CLINICAL TRIALS CAN IMPROVE MEASURES
Ben Cox discusses the key challenges, principles and advantages of following a user-experience approach to digital health technologies in clinical trials.
EXPERT VIEW
Sylvia Kaiser
HOW RECENT NFC ADVANCES ENABLE ANTI-COUNTERFEIT DRUG CONTAINMENT & SUPPORT ADHERENCE
Sylvia Kaiser-Kershaw discusses how recent near-field communication tagging advancements can enable pharmaceutical companies to protect the authenticity and integrity of their products, while also making it easier for healthcare professionals and patients to use medications more effectively through intelligent drug delivery systems.
EARLY INSIGHT
Louisa Harvey
No Type
NO TYPE: AN APP TO PREDICT PATIENTS’ LIKELIHOOD TO TAKE MEDICATION AS PRESCRIBED
Louisa Harvey, Alper Hulusi, Bjarki Holm and Stefan Olafsson introduce their quick and accessible app for identifying whether or not a patient is likely to take their medication as prescribed.
EXPERT VIEW
Gabrielle Whitworth-Smith
CYBERSECURITY AND THE CHALLENGES OF CLOUD CONNECTIVITY
Gabrielle Whitworth-Smith and Thomas Watts look at the benefits and risks associated with cloud connectivity and the accompanying cybersecurity challenges.
EXPERT VIEW
Napoleon Monroe
CONNECTIVITY IN HEALTHCARE – FROM THE MILLENNIUM TO THE PANDEMIC AND BEYOND
Napoleon Monroe looks back at the factors that influenced the underwhelming uptake of connectivity-enabling technologies in the healthcare sector over the first two decades of the 21st century, how the covid-19 pandemic changed everything and what current healthcare challenges connectivity might solve.
CONNECTIVITY
Michael Earl
Owen Mumford
SUPPORTING PATIENTS ON THE ROAD TO SELF-CARE
Michael Earl discusses the importance of transitioning current healthcare models to embrace patient self-management and how advanced drug delivery device technologies, such as connectivity, can ease this burden on overstretched healthcare services.
EXPERT VIEW
Paul Edalat
SMART DRUG DELIVERY DEVICES IMPROVE MEDICATION ADHERENCE: HERE’S HOW
Paul Edalat and Mehdi Hatamian take an in-depth look at medication non-adherence and how technology can be used to improve compliance rates and optimise patient outcomes.
Top
